- Presentations
- 2
- Markets
- 1
Tabrecta is a brand of Capmatinib marketed by Novartis Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Capmatinib
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg tablet, 200 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tabrecta 150 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Tabrecta 200 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tabrecta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.